Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SBC
SBC logo

SBC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
3.120
Open
3.110
VWAP
3.08
Vol
70.59K
Mkt Cap
315.74M
Low
3.060
Amount
217.64K
EV/EBITDA(TTM)
3.20
Total Shares
102.85M
EV
203.81M
EV/OCF(TTM)
6.37
P/S(TTM)
1.86
SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.
Show More

Events Timeline

(ET)
2026-05-14
06:40:00
SBC Medical Reports Q1 Revenue of $43M, Below Expectations
select
2026-03-27 (ET)
2026-03-27
16:30:00
Major Averages Drop Due to Strait of Hormuz Incidents
select
2026-03-27
12:00:00
Major Averages Decline Amid Middle East Tensions
select
2026-03-27
06:50:00
SBC Medical Q4 Revenue at $40M, Below Consensus
select
2026-03-27
06:50:00
SBC Medical Reports 11% Increase in Average Revenue per Customer in Q4
select
2026-03-24 (ET)
2026-03-24
08:20:00
SBC Medical Group Launches SBC Wellness 2.0 Platform
select

News

Newsfilter
7.5
05-22Newsfilter
SBC Medical Opens New Dermatology Section in Thailand
  • New Business Launch: SBC Medical, in partnership with BLEZ ASIA, inaugurates a new aesthetic dermatology section at BLEZ CLINIC in Bangkok's Asok district, with services set to commence in June 2026, marking a significant milestone in the company's Thai market efforts.
  • Market Opportunity: With Thailand's aesthetic healthcare market experiencing rapid growth, SBC Medical aims to leverage its collaboration with BLEZ ASIA to meet the high-quality service demands of Japanese expatriates, thereby enhancing its competitive position.
  • Service Features: The new dermatology section will focus on pico laser treatments for pigmentation and spot removal, ensuring a safe and professional medical environment for Japanese expatriates, which is crucial for building customer trust.
  • Strategic Expansion Plan: Following the establishment of a strong reputation in Asok, SBC Medical plans to gradually expand into the broader Thai market and across ASEAN, committed to delivering high-quality medical services that cater to local needs and create new market value.
seekingalpha
9.5
05-14seekingalpha
SBC Medical Group Q1 2026 Earnings Call Insights
  • Revenue Decline Analysis: Total revenues for Q1 2026 were $43 million, reflecting a 9% year-over-year decline primarily due to fee structure revisions implemented in April last year, which negatively impacted franchising revenue by $6.2 million and management services revenue by $2.4 million, totaling an $8.7 million decrease, indicating challenges in revenue structure adjustments.
  • Profitability Decline: Net income decreased year-over-year, partly due to a one-time life insurance gain of $8.7 million in the prior year; however, excluding the impact of fee structure revisions, underlying revenue grew by 11% year-over-year, demonstrating potential business resilience.
  • AI Strategy Advancement: The company is promoting an AI initiative aimed at driving top-line growth through enhanced customer experiences while also enabling a leaner, more efficient organization, with management expressing optimism about future growth as the impact of fee structure adjustments rolls off.
  • Cash Flow and Investment Priorities: Management emphasized that while the current share repurchase program is not a priority, the company has a strong cash position and plans to prioritize growth investments, particularly in seeking M&A opportunities within the competitive Japanese aesthetic market.
seekingalpha
9.5
05-14seekingalpha
SBC Medical Group Q1 Earnings Report
  • Earnings Highlights: SBC Medical Group reported a Q1 GAAP EPS of $0.11, reflecting resilience in the current market despite a 9.1% year-over-year decline, indicating ongoing profitability amidst challenges.
  • Revenue Performance: The company generated $43 million in revenue for Q1, down 9.1% year-over-year and missing market expectations by $5.87 million, highlighting challenges in revenue growth that could impact investor confidence moving forward.
  • Secondary Offering Announcement: SBC Medical announced a secondary offering of 3.1 million shares by a selling stockholder, aimed at strengthening its capital structure and providing funding for future expansion, demonstrating a proactive approach to market opportunities.
  • Analyst Ratings: While the Q1 GAAP EPS of $0.14 beat expectations by $0.03, the revenue of $39.57 million fell short of projections, reflecting a cautious market sentiment regarding the company's future performance and potential stock price implications.
Newsfilter
9.5
05-14Newsfilter
SBC Medical Reports Q1 2026 Financial Results with Significant Declines
  • Revenue Decline: In Q1 2026, total revenues were $43 million, reflecting a 9% year-over-year decrease primarily due to a franchise fee structure reform implemented in April 2025, indicating challenges in revenue growth for the company.
  • Significant Net Income Drop: Net income attributable to SBC Medical was $11 million, a 47% year-over-year decline, with a net income margin of 26%, down 19 percentage points from the previous year, highlighting a substantial weakening in profitability.
  • Customer Growth and Retention: Despite revenue challenges, the number of customers reached 6.76 million over the past twelve months, a 10% year-over-year increase, with a repeat visit rate of 72%, indicating the company's continued market appeal in customer retention.
  • Future Strategic Direction: The company plans to advance its multi-brand strategy, expand its non-aesthetic medical business, and enhance service quality through AI utilization, aiming to adapt to market changes and achieve sustainable growth.
Yahoo Finance
4.5
05-11Yahoo Finance
European Stock Market Volatility and Undervalued Stocks Analysis
  • Market Volatility Analysis: The European stock market has recently experienced volatility, with the pan-European STOXX Europe 600 Index posting modest gains as investor sentiment was buoyed by easing geopolitical tensions and strong corporate earnings, indicating a search for stability amidst uncertainty.
  • Undervalued Stocks Identification: In the current market environment, identifying undervalued stocks is crucial, particularly those potentially trading below their intrinsic value, allowing investors to optimize their portfolios through these opportunities.
  • SNGN Romgaz Financial Overview: SNGN Romgaz SA has a market cap of RON 52.03 billion, with full-year sales reaching RON 8.03 billion and net income at RON 3.35 billion in 2022, while projected annual growth of 10.9% indicates strong competitiveness in the Romanian market.
  • Alleima Future Outlook: Alleima AB is currently trading at SEK 83.70, significantly below its estimated future cash flow value of SEK 112.76, and despite a decline in first-quarter sales to SEK 4.58 billion, it is expected to grow at an annual rate of 28%, far exceeding the Swedish market's average of 8.9%.
Newsfilter
9.5
05-01Newsfilter
SBC Medical Group to Release Q1 2026 Financial Results
  • Earnings Release Schedule: SBC Medical Group plans to release its financial results for the first quarter ended March 31, 2026, before the U.S. market opens on May 14, 2026, which is expected to provide investors with key financial data and operational performance insights.
  • Conference Call Details: Management will host an earnings conference call on the same day at 8:30 a.m. Eastern Time, followed by a Q&A session with analysts and investors, aimed at enhancing transparency and fostering engagement with stakeholders.
  • Company Background: SBC Medical Group is a Medical Services Organization providing management support across various healthcare fields, including aesthetic healthcare and orthopedics, actively expanding its presence in the U.S. and Asia, demonstrating its commitment to a global strategy.
  • NASDAQ Listing Achievement: Since its listing on NASDAQ in September 2024, SBC Medical Group was included in the Russell 3000® Index in June 2025, marking an increase in its recognition and influence within the U.S. equity market.
Wall Street analysts forecast SBC stock price to rise
1 Analyst Rating
Wall Street analysts forecast SBC stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
9.00
Averages
9.00
High
9.00
Current: 0.000
sliders
Low
9.00
Averages
9.00
High
9.00
BTIG
Sam Eiber
initiated
$8
AI Analysis
2026-03-06
Reason
BTIG
Sam Eiber
Price Target
$8
AI Analysis
2026-03-06
initiated
Reason
BTIG analyst Sam Eiber initiated coverage of SBC Medical Group with a Buy rating and $8 price target. SBC is the leading aesthetic medical group in Japan with more than 250 franchises and over 6.5M annual patient visits, the analyst tells investors in a research note. The firm says the shares represent an opportunity for investors looking to own an outside of the U.S. business that has "numerous growth prospects" and is trading at a discount to peers.
Maxim
Maxim
initiated
$9
2025-11-05
Reason
Maxim
Maxim
Price Target
$9
2025-11-05
initiated
Reason
Maxim initiated coverage of SBC Medical Group with a Buy rating and $9 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SBC
Unlock Now

Valuation Metrics

The current forward P/E ratio for SBC Medical Group Holdings Inc (SBC.O) is 6.46, compared to its 5-year average forward P/E of 4.30. For a more detailed relative valuation and DCF analysis to assess SBC Medical Group Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
4.30
Current PE
6.46
Overvalued PE
8.36
Undervalued PE
0.23

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.73
Current EV/EBITDA
2.06
Overvalued EV/EBITDA
2.20
Undervalued EV/EBITDA
-0.74

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.27
Current PS
1.62
Overvalued PS
2.44
Undervalued PS
0.11

Financials

AI Analysis
Annual
Quarterly

Whales Holding SBC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is SBC Medical Group Holdings Inc (SBC) stock price today?

The current price of SBC is 3.07 USD — it has decreased -0.97

What is SBC Medical Group Holdings Inc (SBC)'s business?

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

What is the price predicton of SBC Stock?

Wall Street analysts forecast SBC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SBC is9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SBC Medical Group Holdings Inc (SBC)'s revenue for the last quarter?

SBC Medical Group Holdings Inc revenue for the last quarter amounts to 43.06M USD, decreased -9.02

What is SBC Medical Group Holdings Inc (SBC)'s earnings per share (EPS) for the last quarter?

SBC Medical Group Holdings Inc. EPS for the last quarter amounts to 0.11 USD, decreased -47.62

How many employees does SBC Medical Group Holdings Inc (SBC). have?

SBC Medical Group Holdings Inc (SBC) has 863 emplpoyees as of May 26 2026.

What is SBC Medical Group Holdings Inc (SBC) market cap?

Today SBC has the market capitalization of 315.74M USD.